XML 28 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 4,588,658 $ 17,350,116
Short-term investments 10,554,966 12,863,420
Accounts receivable 481,447 467,909
Accounts receivable from affiliated entity 134,320 38,406
Prepaid expenses and other current assets 487,721 746,049
Prepaid expenses and other current assets from affiliated entity 686,626 441,186
Total current assets 16,933,738 31,907,086
Restricted cash 100,323 100,059
Fixed assets, net 391,527 295,785
Intangible assets, net 7,939,741 9,310,485
Goodwill 10,113,371 10,113,371
Investment in affiliated entity 8,253,717 9,071,513
Investment in common stock warrants 520,600 100,000
Other assets 223,056 208,262
Total assets 44,476,073 61,106,561
Current liabilities:    
Accounts payable and accrued expenses 3,133,620 4,318,942
Accounts payable and accrued expenses due to affiliated entity 110,101 20,344
Accrued clinical trial expenses 1,384,462 1,059,372
Common stock warrants 6,162,948 5,176,319
Deferred revenue 84,146 79,502
Deferred revenue from affiliated entity 401,042 388,542
Total current liabilities 11,276,319 11,043,021
Deferred revenue, net of current portion 90,271 80,450
Deferred revenue from affiliated entity, net of current portion 1,680,444 1,961,694
Deferred rent 70,023 80,875
Deferred tax liabilities 78,859 78,859
Total liabilities 13,195,916 13,244,899
Inovio Pharmaceuticals, Inc. stockholders' equity:    
Common stock 137,055 134,968
Additional paid-in capital 259,636,082 257,235,707
Accumulated deficit (229,101,378) (210,091,174)
Accumulated other comprehensive income 93,102 35,393
Total Inovio Pharmaceuticals, Inc. stockholders' equity 30,764,861 47,314,894
Non-controlling interest 515,296 546,768
Total stockholders' equity 31,280,157 47,861,662
Total liabilities and stockholders' equity $ 44,476,073 $ 61,106,561